Active substance
Results for the substance spesolimab
2 results
About this active substance
Spesolimab is a monoclonal antibody used for the treatment of autoimmune inflammatory diseases, such as generalized pustular psoriasis. It works by inhibiting interleukin-36 (IL-36), reducing inflammation and associated symptoms.
The medication is administered intravenously, as directed by a doctor, usually in a hospital or specialized clinic. It is important for patients to be monitored to prevent adverse reactions.
Patients should be aware of potential side effects, such as injection site reactions, fever, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, fever, and nausea. In rare cases, severe reactions such as anaphylactic reactions or serious infections may occur. Patients should be informed of these risks before administration.
The medication is administered intravenously, as directed by a doctor, usually in a hospital or specialized clinic. It is important for patients to be monitored to prevent adverse reactions.
Patients should be aware of potential side effects, such as injection site reactions, fever, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, fever, and nausea. In rare cases, severe reactions such as anaphylactic reactions or serious infections may occur. Patients should be informed of these risks before administration.
-
-
SPEVIGO 150mg solution for injection in pre-filled syringe LEO PHARMA ORIGINAL MEDICINE